on B.R.A.I.N. Biotechnology Research And Information Network AG (ETR:DE000520)
BRAIN Biotech AG Secures New Revolving Credit Facility
BRAIN Biotech AG has signed a new revolving credit facility with MP Beteiligungs-GmbH, valued at €9.0 million. The agreement, effective July 13, 2026, will conclude on December 31, 2028. The interest on the drawn loan amount will be charged at a variable rate, based on a 6-Month-Forward-Euribor plus 233 basis points annually.
This credit line aims to support general corporate financing and scheduled debt servicing. It marks a significant step for the company in securing flexible funding for future financial obligations.
Headquartered in Zwingenberg, Germany, BRAIN Biotech AG operates with a focus on biotechnology innovations. The agreement reflects the company's strategic financial planning and commitment to maintaining operational fluidity.
R. P.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all B.R.A.I.N. Biotechnology Research And Information Network AG news